Aliases & Classifications for Astigmatism

About this section

Summaries for Astigmatism

About this section
Disease Ontology:11 A refractive error characterized by the optics of the eye to focus a point object into a sharp focused image on the retina, has symptom blurred vision.

MalaCards based summary: Astigmatism is related to nystagmus 5, congenital, x-linked and irregular astigmatism, and has symptoms including blurred vision, aniseikonia and aniseikonia. An important gene associated with Astigmatism is CACNA1F (Calcium Voltage-Gated Channel Subunit Alpha1 F). Affiliated tissues include eye, retina and endothelial.

Wikipedia:71 Astigmatism is a type of refractive error in which the eye does not focus light evenly on the retina.... more...

Related Diseases for Astigmatism

About this section

Diseases related to Astigmatism via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 89)
idRelated DiseaseScoreTop Affiliating Genes
1nystagmus 5, congenital, x-linked29.8CER1, GREM1
2irregular astigmatism12.1
3regular astigmatism12.0
4refractive error11.3
5keratoconus11.1
6amblyopia11.0
7ectopia lentis et pupillae10.8
8microcephaly with or without chorioretinopathy, lymphedema, or mental retardation10.8
9lymphedema-distichiasis syndrome10.8
10nystagmus 6, congenital, x-linked10.8
11aland island eye disease10.8
12megalocornea 1, x-linked10.8
13nystagmus 1, congenital, x-linked10.8
14lacrimal duct defect10.7
15nystagmus 7, congenital, autosomal dominant10.7
16keratoconus 510.7
17macrocephaly/megalencephaly syndrome, autosomal recessive10.7
18nystagmus 2, congenital, autosomal dominant10.7
19nystagmus 3, congenital, autosomal dominant10.7
20nystagmus 4, congenital, autosomal dominant10.7
21keratoconus 810.7
22keratoconus 110.7
23meesmann corneal dystrophy10.7
24retinitis pigmentosa10.7
25cataract10.5
26myopia10.5
27kyphoscoliotic heart disease10.4KRT12, KRT3
28stromal dystrophy10.4KRT12, KRT3
29oral mucosa leukoplakia10.4FRMD7, GPR143
30systolic heart failure10.3FRMD7, GPR143
31liver disease10.3KRT12, KRT3
32epidermolysis bullosa simplex, weber-cockayne type10.2KRT12, KRT3
33mucopolysaccharidosis10.2FRMD7, GPR143
34acute serous otitis media10.2KRT12, KRT3
35malignant tumor of undescended testis10.1ADAMTSL4, GREM1
36corneal dystrophy, epithelial basement membrane10.1KRT12, KRT3
37anisometropia10.1
38presbyopia10.0
39endotheliitis10.0
40cerebral artery occlusion10.0IFITM2, KRT12, KRT3
41epiblepharon9.9
42corneal ectasia9.8
43pellucid marginal degeneration9.8
44hemangioma9.8
45corneal degeneration9.8
46retinitis9.8
47eye disease9.8
48keratopathy9.7
49bullous keratopathy9.7
50capillary hemangioma9.7

Graphical network of the top 20 diseases related to Astigmatism:



Diseases related to astigmatism

Symptoms & Phenotypes for Astigmatism

About this section

Symptoms:

 11
  • blurred vision

UMLS symptoms related to Astigmatism:


aniseikonia

Drugs & Therapeutics for Astigmatism

About this section

Drugs for Astigmatism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 102)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Hyaluronic acidapproved, vet_approvedPhase 44399004-61-953477741, 24759
Synonyms:
Hyaluronan
Hyaluronate
Hyaluronic acid
Hylartil
Hyruan Plus
Luronit
 
Macronan
Mucoitin
Nutra-HAF
Q 5AQ
Sepracoat
Sepragel Sinus
Sofast
Synvisc
2
DipivefrinapprovedPhase 4, Phase 39452365-63-63105
Synonyms:
( -)-2,2-Dimethylpropansaeure-4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylenester
( -)-4-(1-Hydroxy-2-methylaminoethyl)-o-phenylendipivalat
(+-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol 3,4-dipivalate
(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
(+-)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
(RS)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol
1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol
2,2-Dimethylpropanoic acid 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate)
52365-63-6
AB00514686
AC1L1F6K
AKOS003662293
AKPro
BPBio1_000688
BRD-A47494775-003-03-0
BSPBio_000624
C06963
C19H29NO5
CHEBI:4646
CID3105
D02349
DB00449
Dipivalyl Epinephrine
 
Dipivefrin
Dipivefrin (USAN)
Dipivefrin HCL
Dipivefrin [USAN]
Dipivefrina
Dipivefrina [INN-Spanish]
Dipivefrine
Dipivefrine (INN)
Dipivefrinum
Dipivefrinum [INN-Latin]
Dipivéfrine
K 30081
L000915
LS-121419
NCGC00179499-01
Ophtho-Dipivefrin
Prestwick0_000632
Prestwick1_000632
Prestwick2_000632
Prestwick3_000632
Pro-Epinephrine
Propine
Propine C Cap B.I.D.
SPBio_002843
UNII-8Q1PVL543G
[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate
dipivalyl epinephrine
dipivefrin
nchembio747-comp3
3
MentholapprovedPhase 4, Phase 323532216-51-516666
Synonyms:
(−
()-Menthol
(+)-Neo-menthol
(+)-p-Menthan-3-ol
(+-)-(1R*,3R*,4S*)-Menthol
(+-)-Menthol
(+/-)-Menthol
(+/-)-p-Menthan-3-ol
(-)-(1R,3R,4S)-Menthol
(-)-Menthyl alcohol
(-)-menthol
(-)-p-Menthan-3-ol
(-)-trans-p-Menthan-cis-ol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(-)-MENTHOL
(1R,3R,4S)-(-)-Menthol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1S, 2S, 5R)-(+)-Neomenthol
(1S,2R,5R)-(+)-Isomenthol
(1S,2R,5S)-(+)-Menthol
(1S,2R,5S)-Menthol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1r,2s,5r)-(-)-menthol
(L)-MENTHOL
(R)-(-)-Menthol
(r)-(-)-menthol
)-Menthol
--MENTHOL
1-Menthol
1490-04-6
15356-60-2
15356-70-4
15785_RIEDEL
15785_SIAL
19863P
2-Isopropyl-5-methylcyclohexanol
20747-49-3
2216-51-5
3-p-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
491-02-1
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-methyl-2-(propan-2-yl)cyclohexanol
5-methyl-2-propan-2-ylcyclohexan-1-ol
551376_ALDRICH
551376_FLUKA
588733_ALDRICH
613290_ALDRICH
613290_FLUKA
63660_FLUKA
63670_ALDRICH
63670_FLUKA
63975-60-0
6C6A4A8C-A054-468C-A1F0-F29E39838CF2
89-78-1
98167-53-4
AC1L1B2E
AC1L28FR
AC1Q1NQ2
AC1Q2QQM
AI3-08161
AI3-52408
AKOS000119740
AR-1J3337
BB_NC-0057
BRN 1902288
BRN 3194263
BSPBio_003062
C00400
C10H20O
CCRIS 3728
CCRIS 375
CCRIS 4666
CCRIS 9231
CHEBI:15409
CHEBI:545611
CHEMBL256087
CHEMBL470670
CID1254
CID16666
Caswell No. 540
D-(-)-Menthol
D-p-Menthan-3-ol
D00064
D008610
D04849
D04918
DB00825
DivK1c_000820
EINECS 201-939-0
EINECS 207-724-8
EINECS 216-074-4
EINECS 218-690-9
EINECS 239-387-8
EINECS 239-388-3
EPA Pesticide Chemical Code 051601
FEMA No. 2665
Fisherman's friend lozenges
Fisherman's friend lozenges (TN)
HMS1922G13
HMS2092L14
HMS502I22
 
HSDB 5662
HSDB 593
Headache crystals
Hexahydrothymol
I06-1216
I14-7371
IDI1_000820
KBio1_000820
KBio2_000785
KBio2_003353
KBio2_005921
KBio3_002562
KBioSS_000785
L-(-)-Menthol
L-(-)-menthol
L-Menthol
L-menthol
LMPR0102090001
LS-2353
LS-57201
LS-886
LS-89531
LS-89533
Levomenthol
Levomenthol [INN:BAN]
Levomentholum
Levomentholum [INN-Latin]
Levomentol
M0321
M0545
M2772_SIAL
MENTHOL
MLS002207256
Menthacamphor
Menthol
Menthol (USP)
Menthol (VAN)
Menthol natural
Menthol natural, brazilian
Menthol racemic
Menthol racemique
Menthol racemique [French]
Menthol solution
Menthol, (1alpha,2beta,5alpha)-Isomer
Menthomenthol
Menthyl alcohol
MolPort-000-849-729
MolPort-001-793-392
NCGC00159382-02
NCGC00159382-03
NCGC00164247-01
NCGC00164247-02
NCI-C50000
NINDS_000820
NOOLISFMXDJSKH-KXUCPTDWBX
NSC 2603
NSC 62788
NSC2603
NSC62788
Neoisomenthol
Peppermint camphor
RACEMIC MENTHOL U.S.P.
Racementhol
Racementhol [INN:BAN]
Racementholum
Racementholum [INN-Latin]
Racementol
Racementol [INN-Spanish]
Racemic menthol
Robitussin Cough Drops
SDCCGMLS-0066659.P001
SMR001306785
SPBio_000869
SPECTRUM1503134
STK802468
Spectrum2_000855
Spectrum3_001561
Spectrum5_001060
Spectrum_000305
Tra-kill tracheal mite killer
U.S.P. Menthol
U.S.p. Menthol
UNII-BZ1R15MTK7
UNII-L7T10EIP3A
UNII-YS08XHA860
W266507_ALDRICH
W266523_ALDRICH
W266590_ALDRICH
WLN: L6TJ AY1&1 BQ D1
WLN: L6TJ AY1&1 DQ D1 -L
ZINC01482164
cis-1 ,3-trans-1,4-(+-)-menthol
cis-1,3-trans-1,4-(+-)-menthol
d,l-Menthol
d-Menthol
d-Neomenthol
dl-3-p-Menthanol
dl-Menthol
dl-Menthol (JP15)
l-(-)-Menthol
l-Menthol
l-Menthol (JP15)
l-Menthol (TN)
l-Menthol (natural)
nchembio862-comp1
p-Menthan-3-ol
rac-Menthol
4
FluorouracilapprovedPhase 4179151-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
5
Bevacizumabapproved, investigationalPhase 41968216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
6AnestheticsPhase 4, Phase 2, Phase 39001
7ProxymetacainePhase 440
8Pharmaceutical SolutionsPhase 4, Phase 2, Phase 3, Phase 17793
9Neurotransmitter AgentsPhase 417734
10Adrenergic AgonistsPhase 42877
11Adrenergic AgentsPhase 45140
12Antimetabolites, AntineoplasticPhase 47171
13Immunosuppressive AgentsPhase 412770
14Angiogenesis Modulating AgentsPhase 44072
15Angiogenesis InhibitorsPhase 44143
16AntimetabolitesPhase 411774
17
Lidocaineapproved, vet_approvedPhase 2, Phase 31226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
18
Folic Acidapproved, nutraceutical, vet_approvedPhase 2, Phase 3, Phase 1427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
19
Riboflavinapproved, nutraceutical, vet_approvedPhase 2, Phase 3, Phase 116583-88-5493570
Synonyms:
(-)-Riboflavin
1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol
1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol
6,7-Dimethyl-9-D-ribitylisoalloxazine
6,7-Dimethyl-9-ribitylisoalloxazine
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-Benzo[g]pteridine-2,4(3H,10H)-dione
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine
7,8-Dimethyl-10-ribitylisoalloxazine
Beflavin
Beflavine
Benzo[g]pteridine riboflavin deriv.
E 101
E101
Flavaxin
Flavin BB
Flaxain
Food Yellow 15
 
Hyre
Lactobene
Lactoflavin
Lactoflavine
Ribipca
Ribocrisina
Riboderm
Riboflavina
Riboflavine
Riboflavinum
Ribosyn
Ribotone
Ribovel
Russupteridine yellow III
San Yellow B
Vitaflavine
Vitamin B2
Vitamin G
Vitasan B2
20
Flavin MononucleotideexperimentalPhase 2, Phase 36146-17-8643976
Synonyms:
FMN
Flanin
Flavine mononucleotide
Flavol
Riboflavin
Riboflavin 5'-monophosphate
Riboflavin 5'-phosphate
Riboflavin Mononucleotide
Riboflavin monophosphate
 
Riboflavin phosphate
Riboflavin-5'-phosphate na
Riboflavin-5-phosphate
Riboflavine 5'-monophosphate
Riboflavine 5'-phosphate
Riboflavine dihydrogen phosphate
Riboflavine monophosphate
Riboflavine phosphate
Riboflavine-5'-phosphate
Vitamin B2 phosphate
21Photosensitizing AgentsPhase 2, Phase 3, Phase 1476
22VitaminsPhase 2, Phase 3, Phase 15095
23Ophthalmic SolutionsPhase 3, Phase 1, Phase 21092
24MitomycinsPhase 3, Phase 1233
25Peripheral Nervous System AgentsPhase 2, Phase 322776
26Vitamin B ComplexPhase 2, Phase 3, Phase 14229
27Sodium Channel BlockersPhase 2, Phase 31515
28Trace ElementsPhase 2, Phase 3, Phase 15802
29MicronutrientsPhase 2, Phase 3, Phase 15802
30Central Nervous System DepressantsPhase 2, Phase 312806
31Anti-Arrhythmia AgentsPhase 2, Phase 32969
32DextransPhase 2, Phase 3, Phase 199
33Dermatologic AgentsPhase 2, Phase 3, Phase 15674
34Anesthetics, LocalPhase 2, Phase 33272
35Diuretics, Potassium SparingPhase 2, Phase 31827
36Protective AgentsPhase 37190
37Vasodilator AgentsPhase 33438
38Polymethyl MethacrylatePhase 342
39Blood SubstitutesPhase 3, Phase 1, Phase 2246
40Plasma SubstitutesPhase 3, Phase 1, Phase 2233
41AnticoagulantsPhase 3, Phase 1, Phase 22516
42FolateNutraceuticalPhase 2, Phase 3, Phase 14279
43Vitamin B2NutraceuticalPhase 2, Phase 3, Phase 1165
44Vitamin B9NutraceuticalPhase 2, Phase 3, Phase 14279
45Anti-Bacterial AgentsPhase 2, Phase 110884
46MydriaticsPhase 2, Phase 1, Early Phase 1763
47Anti-Infective AgentsPhase 221402
48Nucleic Acid Synthesis InhibitorsPhase 14855
49Alkylating AgentsPhase 14694
50Antibiotics, AntitubercularPhase 16972

Interventional clinical trials:

(show top 50)    (show all 252)
idNameStatusNCT IDPhase
1Effect of Posterior Corneal Toricity on Refractive Outcome of PseudophakiaUnknown statusNCT01554761Phase 4
2Clinical Evaluation of Toric Intraocular Lens Made by AurolabUnknown statusNCT01396616Phase 4
3A Intra-patient Comparison of Closed Loop and Plate Haptic Toric Intraocular LensesUnknown statusNCT02264457Phase 4
4Multi Laser Platform Comparison Study for LASIKUnknown statusNCT00770094Phase 4
5Use of Toric Intraocular Lens to Neutralize Keratometric AstigmatismCompletedNCT00925886Phase 4
6Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal AstigmatismCompletedNCT01763151Phase 4
7Intrastromal Corneal Ring for High Astigmatism on PostkeratoplastyCompletedNCT01018797Phase 4
8Clinical Performance of Biofinity Toric Versus Air Optix for AstigmatismCompletedNCT01965288Phase 4
9Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy.CompletedNCT01885780Phase 4
10Safety and Effectiveness of the Akreos Toric Intraocular Lens.CompletedNCT00825513Phase 4
11Clinical Performance of Habitual Hydrogel vs. Silicone Hydrogel Toric Contact LensesCompletedNCT02142361Phase 4
12Contralateral Comparison of Three Excimer Laser Systems in Performing LASIKCompletedNCT00821236Phase 4
13Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled TrialCompletedNCT01279031Phase 4
14AcrySof Toric Clinical ResultsCompletedNCT01214863Phase 4
15Low Cylinder ToricCompletedNCT00732030Phase 4
16An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic PatientsCompletedNCT01173198Phase 4
17Visual Outcomes After Implantation of a New Multifocal Intraocular LensCompletedNCT01505816Phase 4
18Daily Wear Corneal Infiltrative Event StudyCompletedNCT00937105Phase 4
19Co-Axial Micro-Incision Versus Co-Axial Small Incision Cataract Surgery Using the Stellaris Enhancement SystemCompletedNCT01261975Phase 4
20Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate IncisionsRecruitingNCT02763124Phase 4
21High Resolution Wavefront-guided vs. Wavefront Optimized LASIKRecruitingNCT02565537Phase 4
22Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Lens (IOL)RecruitingNCT02649842Phase 4
23Prospective Investigation of SUPRACOR Visual Outcomes of Presbyopic Hyperopic Patients With and Without AstigmatismActive, not recruitingNCT01628146Phase 4
24LASIK Using the Alcon Allegretto Wavefront-Guided Excimer Laser vs AMO Visx Wavefront-Guided Excimer LaserActive, not recruitingNCT01454843Phase 4
25Wavefront-guided PRK vs Wavefront-optimized PRKActive, not recruitingNCT02091934Phase 4
26Wavefront-guided Photorefractive Keratectomy (PRK) Versus Wavefront-guided Lasik for MyopiaActive, not recruitingNCT01140594Phase 4
27Strategies for Management of Recurrent PterygiumNot yet recruitingNCT02530801Phase 4
28Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® ToricWithdrawnNCT00761488Phase 4
29Evaluation of the BunnyLens TR Intraocular LensUnknown statusNCT01659801Phase 3
30Intrastromal Correction of Ametropia by a Femtosecond LaserUnknown statusNCT00928122Phase 3
31Comparison of Penetrating Keratoplasty and Deep Lamellar Keratoplasty With the Big Bubble Technique for KeratoconusUnknown statusNCT00371202Phase 3
32Corneal Cross Linking and Topography Guided Excimer Laser TreatmentUnknown statusNCT01682993Phase 3
33Treatment of Keratoconus Using Collagen Cross-LinkingUnknown statusNCT00841386Phase 2, Phase 3
34Economic Evaluation of Femtosecond Laser Assisted Cataract SurgeryUnknown statusNCT01982006Phase 3
35Comparison of Cross-cylinder and Conventional Photorefractive Keratectomy(PRK) in Correcting Medium-high AstigmatismCompletedNCT00663923Phase 3
36The Berkeley Orthokeratology StudyCompletedNCT00000123Phase 3
37Multicenter Evaluation of Safety and Effectiveness of Presbyopic LASIK for HyperopesCompletedNCT00910403Phase 3
38A Prospective Study of Femtosecond Laser Intracorneal LensectomiCompletedNCT01673503Phase 3
39Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical HeterophoriaCompletedNCT00785135Phase 3
40Evaluating the Safety and Efficacy of the KXL System for Corneal Collagen Cross-Linking in Eyes Having KeratoconusRecruitingNCT02638376Phase 3
41Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical TrialRecruitingNCT01604135Phase 3
42Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed AstigmatismActive, not recruitingNCT01675492Phase 3
43SUPRACOR for Myopia and Myopic AstigmatismActive, not recruitingNCT01404884Phase 3
44Clinical Evaluation of CATS Tonometer PrismNot yet recruitingNCT02989909Phase 3
45Complete Easy Rub Comparative Efficacy StudyWithdrawnNCT01019564Phase 3
46Myoring Versus Keraring Implantation for KeratoconusUnknown statusNCT01869517Phase 2
47Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecond Laser SystemCompletedNCT01348854Phase 2
48Wavefront Analyzes and Visual Performance of Three Multifocal Intra-ocular LensesCompletedNCT00876707Phase 1, Phase 2
49Is Non-cycloplegic Photorefraction Applicable for Screening Refractive Risk Factors of Amblyopia?CompletedNCT01308307Phase 2
50Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose SolutionsCompletedNCT01024855Phase 1, Phase 2

Search NIH Clinical Center for Astigmatism


Cochrane evidence based reviews: astigmatism

Genetic Tests for Astigmatism

About this section

Genetic tests related to Astigmatism:

id Genetic test Affiliating Genes
1 Astigmatism27

Anatomical Context for Astigmatism

About this section

MalaCards organs/tissues related to Astigmatism:

36
Eye, Retina, Endothelial, Testes

Publications for Astigmatism

About this section

Articles related to Astigmatism:

(show top 50)    (show all 739)
idTitleAuthorsYear
1
Correction of irregular and induced regular corneal astigmatism with toric IOL after posterior segment surgery: a case series. (28086913)
2017
2
Changes in Astigmatism, Densitometry, and Aberrations After SMILE for Low to High Myopic Astigmatism: A 12-Month Prospective Study. (28068441)
2017
3
Comparison of Toric Foldable Iris-Fixated Phakic Intraocular Lens Implantation and Limbal Relaxing Incisions for Moderate-to-High Myopic Astigmatism. (27593877)
2016
4
Ocular residual astigmatism (ORA) in pre-cataract eyes prior to and after refractive lens exchange. (27624172)
2016
5
Comparison of Astigmatism Induced by Combined Inferior Oblique Anterior Transposition Procedure and Lateral Rectus Recession Alone. (27980365)
2016
6
Long-term follow-up of astigmatic keratotomy for corneal astigmatism after penetrating keratoplasty. (27150121)
2016
7
Analysis of cataract surgery induced astigmatism: Two polar methods comparison. (28040496)
2016
8
Development of a program for toric intraocular lens calculation considering posterior corneal astigmatism, incision-induced posterior corneal astigmatism, and effective lens position. (27541160)
2016
9
Residual astigmatism after toric intraocular lens implantation: Analysis of data from an online toric intraocular lens back-calculator. (27956286)
2016
10
Aspheric Micro-monovision LASIK in Correction of Presbyopia and Myopic Astigmatism: Early Clinical Outcomes in a Chinese Population. (27722755)
2016
11
Evaluation of the diagnostic ability of vector parameters characterizing the corneal astigmatism and regularity in clinical and subclinical keratoconus. (27931882)
2016
12
Total Corneal Astigmatism Measurements: Agreement Between 2 Rotating Scheimpflug Cameras. (28002110)
2016
13
Clinical Performance of a Spherical Hybrid Lens Design in High Regular Astigmatism. (27660920)
2016
14
The Influence of Induced Astigmatism on the Depth of Focus. (27536975)
2016
15
Toric intraocular lens implantation in children with developmental cataract and preexisting corneal astigmatism. (27573881)
2016
16
Authors reply to: toric intraocular lens implantation in children with developmental cataract and preexisting corneal astigmatism by Ram etA al. (27966837)
2016
17
Stability of Keratometric Astigmatism After Non-penetrating Femtosecond Laser Intrastromal Astigmatic Keratotomy Performed During Laser Cataract Surgery. (27027621)
2016
18
A control-matched comparison of flap off and flap on laser-assisted subepithelial keratectomy (LASEK) for the treatment of myopia and myopic astigmatism. (26949353)
2016
19
Development of a nomogram for femtosecond laser astigmatic keratotomy for astigmatism after keratoplasty. (27113878)
2016
20
Transmissive liquid-crystal device for correcting primary coma aberration and astigmatism in biospecimen in two-photon excitation laser scanning microscopy. (27624000)
2016
21
Corneal Astigmatism Stability in Descemet Membrane Endothelial Keratoplasty for Fuchs Corneal Dystrophy. (27191667)
2016
22
Treatment of mixed astigmatism: early clinical outcomes withWaveLight and Technolas excimer lasers. (27513239)
2016
23
Convergence Insufficiency, Accommodative Insufficiency, Visual Symptoms, and Astigmatism in Tohono O'odham Students. (27525112)
2016
24
Long-Term Comparison of Posterior Chamber Phakic Intraocular Lens With and Without a Central Hole (Hole ICL and Conventional ICL) Implantation for Moderate to High Myopia and Myopic Astigmatism: Consort-Compliant Article. (27057883)
2016
25
Trabeculectomy With Moorfields Conjunctival Closure Technique Offers Safety Without Astigmatism Induction. (27120136)
2016
26
Astigmatism Correction With Toric Intraocular Lenses in Descemet Membrane Endothelial Keratoplasty Triple Procedures. (28002107)
2016
27
Internal Astigmatism in Myopes and Non-myopes: Compensation or Constant? (27564515)
2016
28
Correlation of higher order aberrations and components of astigmatism in myopic refractive surgery candidates. (27579454)
2016
29
Combination of Toric and multifocal intraocular lens implantation in bilateral cataract patients with unilateral astigmatism. (28003977)
2016
30
Influence of different types of astigmatism on visual acuity. (27639497)
2016
31
Predictors of femtosecond laser intrastromal astigmatic keratotomy efficacy for astigmatism management in cataract surgery. (27026450)
2016
32
Combined Special Capsular Tension Ring and Toric IOL Implantation for Management of Astigmatism and High Axial Myopia with Cataracts. (28005433)
2016
33
Changes in the axis of astigmatism and in the fundus torsion following inferior oblique muscle weakening. (27138808)
2016
34
Astigmatism in underserved rural areas: a population based study. (27572485)
2016
35
Does astigmatism alter with cycloplegia? (27579457)
2016
36
Off-axis astigmatism in the isolated chicken crystalline lens. (27984063)
2016
37
Surgically induced astigmatism is characterized by optical vectors, not by ratios. (27026473)
2016
38
Distribution of the Anterior and Posterior Corneal Astigmatism in Eyes with Keratoconus. (27066720)
2016
39
Changes in astigmatism and corneal higher-order aberrations after phacoemulsification with toric intraocular lens implantation for mild keratoconus with cataract. (27165708)
2016
40
Effect of fronto-orbital advancement on astigmatism in patients with anterior plagiocephaly. (27567360)
2016
41
Refractive and Quality of Vision Outcomes with Toric IOL Implantation in Low Astigmatism. (28070415)
2016
42
Astigmatism terminology and source references. (27113891)
2016
43
Effect of corneal biomechanical properties on surgically-induced astigmatism and higher-order aberrations after cataract surgery. (28076565)
2016
44
Pseudolentogenic astigmatic effect of multifocal intraocular lenses: non-corneal ocular residual astigmatism (N-CORA) as a new parameter in astigmatic change analysis. (27665612)
2016
45
Single-step transepithelial photorefractive keratectomy in myopia and astigmatism: 18-month follow-up. (27956283)
2016
46
Long-term Visual and Refractive Outcomes After LASIK for High Myopia and Astigmatism From -8.00 to -14.25 D. (27163613)
2016
47
Astigmatism-free high-brightness 1060 nm edge-emitting lasers with narrow circular beam profile. (28059399)
2016
48
Induced Higher-order aberrations after Laser In Situ Keratomileusis (LASIK) Performed with Wavefront-Guided IntraLase Femtosecond Laser in moderate to high Astigmatism. (27000109)
2016
49
Mode-coupling enhancement by pump astigmatism correction in a Ti:Sapphire femtosecond laser. (27958484)
2016
50
Assessment of refractive astigmatism and simulated therapeutic refractive surgery strategies in coma-like-aberrations-dominant corneal optics. (27175371)
2016

Variations for Astigmatism

About this section

Expression for genes affiliated with Astigmatism

About this section
Search GEO for disease gene expression data for Astigmatism.

Pathways for genes affiliated with Astigmatism

About this section

GO Terms for genes affiliated with Astigmatism

About this section

Biological processes related to Astigmatism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1determination of dorsal identityGO:00482639.9CER1, GREM1
2negative regulation of BMP signaling pathwayGO:00305149.9CER1, GREM1
3visual perceptionGO:00076019.3CACNA1F, GPR143, KRT12, VAX2

Molecular functions related to Astigmatism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1BMP bindingGO:00361229.5CER1, GREM1
2morphogen activityGO:00160159.3CER1, GREM1

Sources for Astigmatism

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet